{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:25:23Z","timestamp":1795159523814,"version":"4.10.3"},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T00:00:00Z","timestamp":1089849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p><jats:bold>Objective.\u2002<\/jats:bold> To assess pregnancy outcome after intrauterine transfusion (IUT) for fetal anemia due to red\u2010cell alloimmunization in the Netherlands over 11\u2003years, in order to improve care and counseling.<\/jats:p><jats:p><jats:bold>Methods.\u2002<\/jats:bold> A retrospective cohort study was conducted from January 1, 1988, to January 1, 1999. Data were collected prospectively on all red\u2010cell alloimmunized pregnancies requiring intrauterine blood transfusions. Primary outcome variables were fetal and neonatal survival in relation to the type of antibody, gestational age and presence or absence of hydrops. In addition, we studied short\u2010term neonatal morbidity and procedure\u2010related complications.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> A total of 210 fetuses from 208 pregnancies received 593 transfusions. Overall survival rate was 86%. Survival of hydropic fetuses (78%) was significantly different from those without hydrops (92%). Low survival rates were especially found in hydropic fetuses with the first transfusion at gestational ages of 20\u2003weeks or less (55%) or between 28 and 32\u2003weeks (59%). In maternal rhesus\u2003D [Rh(D)] immunization 89% of fetuses survived, whereas survival in the case of Kell immunization was 58%. All fetuses with anemia due to Rh(c) immunization survived. The overall fatal procedure\u2010related complication rate was 1.7% per procedure, resulting in a fetal loss rate of 4.8%.<\/jats:p><jats:p><jats:bold>Conclusions.\u2002<\/jats:bold> Intrauterine intravascular transfusions are effective in the management of fetal alloimmune anemia. Fetal hydrops, mostly associated with late referral, decreases the chance of survival. To improve the outcome of red\u2010cell alloimmunized pregnancies early diagnosis of fetal anemia and referral to a specialized center are important, enabling the start of treatment before hydrops develops.<\/jats:p>","DOI":"10.1111\/j.0001-6349.2004.00394.x","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T13:22:16Z","timestamp":1089897736000},"page":"731-737","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Treatment of fetal anemia due to red\u2010cell alloimmunization with intrauterine transfusions in the Netherlands, 1988\u20131999"],"prefix":"10.1111","volume":"83","author":[{"given":"Inge L.","family":"Van Kamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans J. C. M.","family":"Klumper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertjan H.","family":"Meerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Oepkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicco A.","family":"Scherjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey H. H.","family":"Kanhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,15]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08304.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00428-0"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13266.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5365.1107"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(89)90080-4"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91314-3"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91549-X"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6313.373"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)90982-1"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1992.02050329.x"},{"key":"e_1_2_7_12_2","first-page":"1465","article-title":"Hemolytische ziekte van de pasgeborene en irregulaire\u2010bloed groepantagonisme in Nederland: prevalentie en morbiditeit. [Haemolytic disease of the newborn and irregular blood group antagonism in the Netherlands: prevalence and morbidity.]","volume":"143","author":"Van Dijk BA","year":"1999","journal-title":"Ned Tijdschr Geneesk"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb00855.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.112970"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb13184.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001063420102"},{"key":"e_1_2_7_17_2","first-page":"1","article-title":"Effect of atracurium or pancuronium on the anemic fetus during and directly after intravascular intrauterine transfusion","volume":"78","author":"Mouw RJC","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(84)90683-5"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb12026.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00113-5"},{"key":"e_1_2_7_21_2","first-page":"203","article-title":"Intrauterine fetal transfusions: Winnipeg 1982","volume":"61","author":"Bowman JM","year":"1983","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349309013343"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199203000-00013"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.116690"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90997-J"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-3782(99)00063-8"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1997.d01-38.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb11662.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.111716"},{"key":"e_1_2_7_30_2","first-page":"286","article-title":"Intravascular transfusion of fetuses with rhesus incompatibility: prediction of fetal outcome by changes in umbilical venous pressure","volume":"80","author":"Hallak M","year":"1992","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_31_2","first-page":"107","volume-title":"Invasive fetal testing and treatment","author":"Harman CR","year":"1995"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198605293142207"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)80061-3"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70178-4"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.341195065035.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood.V90.6.2492","article-title":"Intrauterine transfusions affect fetal T\u2010cell immunity","volume":"90","author":"Vi\u00ebtor HE","year":"1997","journal-title":"Blood"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-6349.2004.00394.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-6349.2004.00394.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0001-6349.2004.00394.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:08:08Z","timestamp":1697378888000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.0001-6349.2004.00394.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.0001-6349.2004.00394.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0001-6349.2004.00394.x","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]},"assertion":[{"value":"2004-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}